Smith & Nephew plc (LON:SN) Given Average Recommendation of “Moderate Buy” by Analysts

Smith & Nephew plc (LON:SN) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is GBX 1,346.20 ($16.91).

A number of equities research analysts recently issued reports on the stock. Barclays reaffirmed an “equal weight” rating and set a GBX 1,150 ($14.45) price target on shares of Smith & Nephew in a research note on Friday, February 9th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,250 ($15.70) price target on shares of Smith & Nephew in a report on Friday, May 3rd. Royal Bank of Canada reiterated an “outperform” rating and issued a GBX 1,500 ($18.84) price target on shares of Smith & Nephew in a research report on Tuesday. Berenberg Bank restated a “buy” rating and set a GBX 1,450 ($18.22) price objective on shares of Smith & Nephew in a research report on Thursday, May 2nd. Finally, JPMorgan Chase & Co. lifted their target price on Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the stock an “overweight” rating in a report on Thursday, May 2nd.

Smith & Nephew Stock Down 0.6 %

LON SN opened at GBX 1,001.50 ($12.58) on Friday. The stock has a 50 day moving average price of GBX 1,009.89 and a 200-day moving average price of GBX 1,036.23. Smith & Nephew has a one year low of GBX 887 ($11.14) and a one year high of GBX 1,316.75 ($16.54). The company has a debt-to-equity ratio of 59.11, a quick ratio of 0.84 and a current ratio of 1.77. The company has a market capitalization of £8.76 billion, a P/E ratio of 4,172.92, a P/E/G ratio of 0.46 and a beta of 0.51.

Smith & Nephew Increases Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.23 per share. This is a boost from Smith & Nephew’s previous dividend of $0.14. The ex-dividend date of this dividend is Thursday, March 28th. This represents a dividend yield of 1.62%. Smith & Nephew’s dividend payout ratio is currently 12,500.00%.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.